Myelofibrosis Treatment is Evolving-Are You Ready?

Attend our live symposium and discover new strategies and therapies that are changing the future of myelofibrosis care. [PRIME]( [Unleashing Emerging Therapies to Modify Myelofibrosis Pathogenesis: Shifting the Treatment Paradigm to Target Deeper Clinical and Molecular Responses]( [REGISTER NOW!]( [Event Details:]( [San Diego, CA]( [Friday, Dec 6, 2024 at 3:00 PM Pacific]( [San Diego Convention Center]( [Room 6DE]( [111 W Harbor Drive San Diego, CA 92101]( [619-525-5000]( [1.5 CME/CE | Live Event / Live Webinar]( Join expert faculty for a deep dive into the latest clinical evidence and personalized treatment of myelofibrosis (MF) with JAK inhibitors and beyond. This satellite symposium, live from the 2024 ASH Annual Meeting, will feature a review of the novel mechanisms of action and disease-modifying potential of emerging MF therapies that will be reinforced through interactive polling questions and a 2D animation video, as well as expert insights on the potential positioning of these agents into MF treatment plans. Attendees can also download an up-to-date Myelofibrosis Clinical Trial Pocket Guide! Don't miss this chance to prepare for the MF treatment shift, with combination therapy and disease modification at the forefront of patient care. Expert Faculty: Jeanne M Palmer, MD Speaker Vice Chair, and Section Chief for Hematology Program Director for the Blood and Marrow Transplant Program Mayo Clinic Phoenix, AZ Pankit Vachhani, MD Speaker Associate Professor of Medicine University of Alabama at Birmingham Birmingham, AL Marina Kremyanskaya, MD, PhD Speaker Associate Professor of Medicine Hematology and Medical Oncology Icahn School of Medicine at Mount Sinai New York, NY [REGISTER NOW!]( [Prime Education] PRIME Education, LLC 114 5th Ave, 14th Floor New York, NY 10011 (954) 718-6055 | [Contact us]( PRIME is a multi-disciplinary accredited provider of continuing medical education. [Unsubscribe from future emails](lst=NL_Prime_Live_Events) | [Contact us]( | [COVID-19 Resource Center](